Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y8S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,882
Award facts
- Contract value 100% obligated
- $15,882.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,882.01 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in a quantity of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 7, 2026, issued on January 6, 2026. Ondansetron is a widely-used antiemetic medication commonly prescribed to prevent nausea and vomiting, particularly in military healthcare and veteran treatment settings. The contract is being performed at the awardee's facility in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills federal medical procurement needs through open competition and has demonstrated capability in delivering essential medications across multiple therapeutic domains to military treatment facilities and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8Y8S?
SPE2DR26F8Y8S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F8Y8S worth?
The government has obligated $15,882 on SPE2DR26F8Y8S.
Is contract SPE2DR26F8Y8S an order under another contract?
Yes. SPE2DR26F8Y8S is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y8S competed?
The extent of competition for SPE2DR26F8Y8S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award